Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16946589 | 0.93 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL11983813 | 0.89 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL18863120 | 0.86 | ALDH1A1 (0.77) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL6687414 | 0.84 | ALDH1A1 (0.88) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL27521802 | 0.84 | SMN1; SMN2 (0.61) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL8455846 | 0.82 | ALDH1A1 (0.80) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL27958345 | 0.82 | TSHR (0.75) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL27705825 | 0.82 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 | |
| SCHEMBL7102961 | 0.81 | ALDH1A1 (0.83) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL10585663 | 0.81 | TSHR (0.65) | ALDH1A1SMN1; SMN2TSHRTDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411439-B1 | PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE | EVONIK DEGUSSA GMBH (DE) | 2016-11-16 | — | — | EP | claimed |
| EP-2520579-B1 | A silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | RICOH CO LTD (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-8871861-B2 | Silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | RICOH COMPANY, LTD. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20120283378-A1 | A SILICONE COMPOUND, PHOTOCURABLE LIQUID INK USING THE SILICONE COMPOUND, AND METHOD OF MANUFACTURING THE INK | RICOH COMPANY, LTD., (JP) | 2012-11-08 | — | — | US | disclosed |
| EP-2520579-A2 | A silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | Ricoh Company, Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| EP-0401502-A1 | Glass-filled poly(arylene sulphide) compositions | PHILLIPS PETROLEUM COMPANY (US) | 1990-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283378-A1 | A SILICONE COMPOUND, PHOTOCURABLE LIQUID INK USING THE SILICONE COMPOUND, AND METHOD OF MANUFACTURING THE INK | DOT1L, L3MBTL3, KDM7A | ALDH1A1 2204/4885SMN1; SMN2 657/4885TSHR 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.